Over the past 12 months, five IPOP markets on Hyperliquid have shown a consistent pattern: the pre-IPO perpetual price trades at a 10.8% to 38.4% discount to the eventual IPO issuance price. This is not a bug. It is a structural signal that retail is mispricing the risk of synthetic securities.
I audit the code, not the charisma. When I first saw the letter from the Hyperliquid Policy Center (HPC) and trade[XYZ] to the SEC on August 19, I ran the numbers. The data came from the same parties pushing the product. No third-party validation. No on-chain verification of the settlement price. The discount itself is a red flag: either the market is pricing in a risk premium for the lack of liquidity, or the perpetual’s funding rate mechanism is bleeding value. Either way, the narrative that this is a bullish expansion for Hyperliquid is premature.
Context: What Is IPOP and Why Does It Matter?
IPOP stands for Initial Price Offering Prediction. It is a synthetic perpetual contract that trades on Hyperliquid’s order book, designed to track the price of a company before its IPO. The contract settles when the IPO occurs, and it carries no equity, no allocation rights, and no voting power. trade[XYZ] acts as the product issuer and likely the primary market maker. HPC, a policy advocacy group, co-signed the letter to the SEC, arguing that IPOP improves price discovery and should be regulated as a commodity derivative rather than a security.
The product is not new. Five IPOP markets have already completed their full lifecycles. The data from these markets shows that the IPOP price consistently undervalues the eventual IPO price. The letter frames this as proof that IPOP provides a “more accurate” pre-IPO price, but I see a different story: the discount reflects the uncertainty of a synthetic market with no regulatory backstop and no independent settlement oracle.
I have been auditing DeFi derivatives since 2020. I standardized rebalancing algorithms for Aave and Compound positions during DeFi Summer. I developed a framework for evaluating AI-agent-driven protocols in 2025. Every time a project claims to have a new “price discovery” mechanism, I check the settlement source. For IPOP, the settlement price is not disclosed. Is it the IPO issue price, the first-day close, or some volume-weighted average? Without that, the risk of manipulation is high.
Core: Order Flow Analysis and the Hidden Incentives
The core of this analysis is order flow. The data provided by HPC and trade[XYZ] shows that the IPOP markets for five companies exhibited a discount of 10.8% to 38.4% relative to the IPO price. Let’s break that down:
- If the market consistently prices the IPO below the offering price, either the market is inefficient or the offering price is inflated. The letter claims the latter, but the data is from the interested party. I need to see the order book history, the funding rate, and the open interest over time to verify.
- The discount is not uniform. The range is wide, suggesting that liquidity is thin and the market is dominated by a few large players. In a market with a single market maker (trade[XYZ]), the spread can be artificially widened or narrowed. The discount could simply be the cost of providing liquidity in a market with no regulatory protection.
- I applied the same due diligence checklist I used during the 2017 ICO audits. The checklist includes: independent audit of settlement logic, transparent oracle, verified on-chain data, and a clear exit mechanism. IPOP fails on all four. The settlement price is not on-chain. The oracle is not named. The contract has not been audited by a third party. The only exit is the IPO event, which is controlled by a centralized entity.
In 2022, I enforced a “no algo-stable” rule that saved my portfolio during the Terra collapse. The same principle applies here: if the settlement price is not verifiable on-chain, the product is effectively a centralized derivative in a decentralized wrapper. The smart money is not trading IPOP; it is shorting HYPE because the regulatory risk is not priced in.
Contrarian: Why Retail Is Buying the Wrong Narrative
The common narrative is that IPOP expands Hyperliquid’s ecosystem, attracts TradFi liquidity, and is a bullish signal for HYPE. Retail sees the discount and thinks it is a mispricing opportunity. They are wrong.
First, the regulatory risk is severe. The letter to the SEC is a proactive attempt to get a favorable classification, but the SEC’s silence is not approval. The Howey test raises red flags: money is invested, profit is expected from the efforts of others (trade[XYZ] and the oracle), and the product references an underlying security. If the SEC classifies IPOP as a security-based swap, it will be forced to register, implement KYC/AML, and restrict US users. Hyperliquid’s current permissionless model cannot accommodate that.
Second, the market structure is fragile. Hyperliquid already faces liquidity fragmentation across dozens of Layer2s. Adding IPOP only slices the already thin order book. The five IPOP markets had low volume, likely dominated by the market maker. The discount is a symptom of illiquidity, not a feature of efficient price discovery.
Third, the data is self-serving. trade[XYZ] is the issuer, market maker, and data provider. There is no independent verification. In my 2020 experience, I learned that when a protocol provides its own performance data, the error bars are always narrower than reality. The 10.8% to 38.4% discount could be the result of a flawed funding rate model, not a reflection of the true IPO price.
Retail is buying the story that IPOP is a bridge to TradFi. Smart money is watching the SEC docket and preparing for a crackdown. The real opportunity is not in trading IPOP; it is in shorting HYPE if the regulatory response is negative.
Takeaway: Actionable Levels and Exit Strategy
This is a process event, not a catalyst. The market has not priced in the regulatory risk. I see three scenarios:
Scenario 1 (40% probability): SEC does not respond or issues a no-action letter. IPOP continues for non-US users. HYPE stays range-bound. No immediate upside.
Scenario 2 (40% probability): SEC issues a warning or begins an investigation. IPOP is restricted for US users. HYPE drops 20-30% as liquidity leaves.
Scenario 3 (20% probability): SEC classifies IPOP as a security-based swap. Hyperliquid is forced to delist or register. HYPE drops 50%+.
Actionable levels: If HYPE is above $X (current price), the risk is not priced in. Set a stop-loss at 15% below the current price. If the SEC docket shows any activity, exit immediately. Diversify into protocols with transparent oracles and independent audits.
Volatility is the price of entry. But in this case, the volatility is not from the market; it is from the regulator. I have seen this playbook before. In 2022, I liquidated all algorithmic stablecoin exposures within minutes of the Terra collapse because I had a pre-planned exit strategy. That same discipline applies here.
Yields are calculated, not guaranteed. The IPOP discount is a yield for the market maker, not for the retail trader. The only guaranteed outcome is that the SEC will eventually act. The question is when.
Diversification is the only safety net. Do not concentrate your portfolio on a single Layer2 or a single product. The IPOP story is interesting, but it is not a reason to go all-in.
I audit the code, not the charisma. The IPOP code is not available for audit. The settlement logic is opaque. The data is from the interested party. Until independent verification is published, treat this as a science experiment, not an investment thesis.
Smart contracts don’t negotiate with regulators. The outcome of this letter will be determined by lawyers, not code. And lawyers are expensive.
